MDL 100907
CAS No. 139290-65-6
MDL 100907 ( MDL-100907;MDL100907;Volinanserin )
Catalog No. M11635 CAS No. 139290-65-6
A potent, selective 5-HT2A receptor antagonist with Ki of 0.36 nM, > 80-fold selectivity for 5-HT2A over other serotonergic receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 74 | In Stock |
|
10MG | 114 | In Stock |
|
25MG | 221 | In Stock |
|
50MG | 285 | In Stock |
|
200MG | 625 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMDL 100907
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective 5-HT2A receptor antagonist with Ki of 0.36 nM, > 80-fold selectivity for 5-HT2A over other serotonergic receptors.
-
DescriptionA potent, selective 5-HT2A receptor antagonist with Ki of 0.36 nM, > 80-fold selectivity for 5-HT2A over other serotonergic receptors; demonstrates a clozapine-like profile of potential antipsychotic activity with low extrapyramidal sid-effect liability, and has a superior CNS safety index.Sleep Disorder Phase 3 Discontinued
-
SynonymsMDL-100907;MDL100907;Volinanserin
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research AreaNeurological Disease
-
IndicationSleep Disorder
Chemical Information
-
CAS Number139290-65-6
-
Formula Weight373.46
-
Molecular FormulaC22H28FNO3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL (267.8 mM); Ethanol: 18 mg/mL (48.2 mM) ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO[C@@H](C1=CC=CC(OC)=C1OC)C2CCN(CCC3=CC=C(F)C=C3)CC2
-
Chemical Name(R)-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperinemethanol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ardayfio PA, et al. J Pharmacol Exp Ther. 2008 Dec;327(3):891-7.
2. Sorensen SM, et al. J Pharmacol Exp Ther. 1993 Aug;266(2):684-91.
3. Kehne JH, et al. J Pharmacol Exp Ther. 1996 May;277(2):968-81.
2. Sorensen SM, et al. J Pharmacol Exp Ther. 1993 Aug;266(2):684-91.
3. Kehne JH, et al. J Pharmacol Exp Ther. 1996 May;277(2):968-81.
molnova catalog
related products
-
VA-012
VA-012 is a potent, selective 5-HT2C receptor positive allosteric modulator (PAM) that exhibits dose-dependent potentiation of 5-HT efficacy with EC50 of 16 nM.
-
Quetiapin
Quetiapine is indicated for the treatment of schizophrenia as well as for the treatment of acute manic episodes associated with bipolar I disorder.
-
Tamoxifen
Tamoxifen is an antagonist of the estrogen receptor in breast tissue.